BSE Live
Jun 02, 16:01Prev. Close
639.75
Open Price
641.80
Bid Price (Qty.)
632.95 (1)
Offer Price (Qty.)
641.50 (23)
NSE Live
Jun 02, 15:47Prev. Close
640.55
Open Price
634.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Nine Months Results of Eris Lifesciences (in Rs. Cr.) | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
Net Sales/Income from operations | 998.77 | 916.65 | 835.97 | 777.68 | 686.52 | |
Other Operating Income | 17.38 | 16.94 | 16.02 | 11.82 | 11.59 | |
Total Income From Operations | 1,016.14 | 933.59 | 851.99 | 789.49 | 698.11 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | 89.05 | 87.56 | 77.34 | 52.86 | 46.64 | |
Purchase of Traded Goods | 84.07 | 52.69 | 81.83 | 59.33 | 58.08 | |
Increase/Decrease in Stocks | 14.56 | 9.50 | -10.73 | 19.26 | -2.72 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 191.89 | 169.54 | 160.67 | 140.73 | 125.73 | |
Depreciation | 47.37 | 36.39 | 27.50 | 31.92 | 21.55 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 242.94 | 231.92 | 219.58 | 234.96 | 198.64 | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 346.25 | 345.99 | 295.79 | 250.44 | 250.19 | |
Other Income | 13.00 | 19.94 | 7.25 | 15.53 | 20.90 | |
P/L Before Int., Excpt. Items & Tax | 359.26 | 365.92 | 303.04 | 265.97 | 271.08 | |
Interest | 17.85 | 2.01 | 0.58 | 1.59 | 18.41 | |
P/L Before Exceptional Items & Tax | 341.40 | 363.91 | 302.46 | 264.38 | 252.67 | |
Exceptional Items | -- | -- | -- | -- | -- | |
P/L Before Tax | 341.40 | 363.91 | 302.46 | 264.38 | 252.67 | |
Tax | 31.23 | 33.43 | 21.21 | 28.21 | 19.71 | |
P/L After Tax from Ordinary Activities | 310.17 | 330.48 | 281.26 | 236.17 | 232.97 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 310.17 | 330.48 | 281.26 | 236.17 | 232.97 | |
Equity Share Capital | 13.60 | 13.59 | 13.58 | 13.75 | 13.75 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 22.81 | 24.33 | 20.71 | 17.17 | 16.94 | |
Diluted EPS | 22.80 | 24.32 | 20.69 | 17.15 | 16.93 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 22.81 | 24.33 | 20.71 | 17.17 | 16.94 | |
Diluted EPS. | 22.80 | 24.32 | 20.69 | 17.15 | 16.93 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
17.05.2023
Eris Life Standalone March 2023 Net Sales at Rs 314.58 crore, up 11.5% Y-o-Y
17.05.2023
Eris Life Consolidated March 2023 Net Sales at Rs 402.80 crore, up 31.66% Y-o-Y
20.01.2023
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y
20.01.2023
Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher